NUP214 fusion genes in acute leukemias: genetic characterization of rare cases

Introduction Alterations of the NUP214 gene (9q34) are recurrent in acute leukemias. Rearrangements of chromosomal band 9q34 targeting this locus can be karyotypically distinct, for example t(6;9)(p22;q34)/DEK::NUP214, or cryptic, in which case no visible change of 9q34 is seen by chromosome banding. Methods We examined 9 cases of acute leukemia with NUP214 rearrangement by array Comparative Genomic Hybridization (aCGH), reverse-transcription polymerase chain reaction (RT-PCR), and cycle sequencing/Sanger sequencing to detect which fusion genes had been generated. Results The chimeras DEK::NUP214, SET::NUP214, and NUP214::ABL1 were found, only the first of which can be readily detected by karyotyping. Discussion The identification of a specific NUP214 rearrangement is fundamental in the management of these patients, i.e., AMLs with DEK::NUP214 are classified as an adverse risk group and might be considered for allogenic transplant. Genome- and/or transcriptome-based next generation sequencing (NGS) techniques can be used to screen for these fusions, but we hereby present an alternative, step-wise procedure to detect these rearrangements.

[1]  C. Bifulco,et al.  PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature , 2022, The oncologist.

[2]  S. Scholl,et al.  Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives , 2021, Cancers.

[3]  K. Borden.  The Nuclear Pore Complex and mRNA Export in Cancer , 2020, Cancers.

[4]  I. Panagopoulos,et al.  TYRO3 Truncation Resulting From a t(10;15)(p11;q15) Chromosomal Translocation in Pediatric Acute Myeloid Leukemia , 2020, AntiCancer Research.

[5]  P. D. Dal Cin,et al.  Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia. , 2020, Blood advances.

[6]  B. Davidson,et al.  Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer , 2020, Oncology letters.

[7]  S. Raimondi,et al.  Acute Myeloid Leukemia , 2020, The New England journal of medicine.

[8]  J. Choi,et al.  Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next‐generation sequencing approaches , 2019, Hematological oncology.

[9]  L. Osnes,et al.  T-cell acute lymphoblastic leukemia in patients 1–45 years treated with the pediatric NOPHO ALL2008 protocol , 2019, Leukemia.

[10]  Vanessa L. Horner,et al.  Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consort , 2019, Genetics in Medicine.

[11]  A Treatment Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia , 2019, Case Medical Research.

[12]  B. Fahrenkrog,et al.  NUP214 in Leukemia: It’s More than Transport , 2019, Cells.

[13]  V. Najfeld,et al.  Myeloid/lymphoid neoplasms with FGFR1 rearrangement , 2018, Leukemia & lymphoma.

[14]  L. Gorunova,et al.  DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15). , 2017, Cancer genomics & proteomics.

[15]  B. Johansson,et al.  Pediatric T‐cell acute lymphoblastic leukemia , 2017, Genes, chromosomes & cancer.

[16]  E. van den Berg,et al.  Guidelines for genomic array analysis in acquired haematological neoplastic disorders , 2016, Genes, chromosomes & cancer.

[17]  Hao Jiang,et al.  B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature. , 2016, Oncology letters.

[18]  T. Haferlach,et al.  The kinetics of relapse in DEK‐NUP214‐positive acute myeloid leukemia patients , 2015, European journal of haematology.

[19]  T. Kameyama,et al.  NUP214-RAC1 and RAC1-COL12A1 Fusion in Complex Variant Translocations Involving Chromosomes 6, 7 and 9 in an Acute Myeloid Leukemia Case with DEK-NUP214 , 2015, Cytogenetic and Genome Research.

[20]  F. Mitelman,et al.  Preface to the Fourth Edition , 2015 .

[21]  Min-hang Zhou,et al.  NUP214 fusion genes in acute leukemia (Review) , 2014, Oncology letters.

[22]  O. Griffith,et al.  Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer) , 2014 .

[23]  A. Lennartsson,et al.  Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR , 2013, BMC Cancer.

[24]  Matthew S. Lebo,et al.  American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders , 2013, Genetics in Medicine.

[25]  A. Ferrando,et al.  The molecular basis of T cell acute lymphoblastic leukemia. , 2012, The Journal of clinical investigation.

[26]  J. O'Reilly,et al.  NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse. , 2011, Leukemia research.

[27]  S. Chiaretti,et al.  SQSTM1-NUP214: a new gene fusion in adult T-cell acute lymphoblastic leukemia , 2010, Haematologica.

[28]  F. Sigaux,et al.  Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome , 2008, Haematologica.

[29]  D. Gilliland,et al.  Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies , 2008, Leukemia.

[30]  U. Gullberg,et al.  Identification of a novel and myeloid specific role of the leukemia‐associated fusion protein DEK‐NUP214 leading to increased protein synthesis , 2008, Genes, chromosomes & cancer.

[31]  Andrew P. Stubbs,et al.  The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. , 2007, Blood.

[32]  A. Ferrando,et al.  Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.

[33]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[34]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[35]  M. Mann,et al.  The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. , 2000, Genes & development.

[36]  A. Hagemeijer,et al.  The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features , 1992 .

[37]  M. Fornerod,et al.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA , 1992, Molecular and cellular biology.

[38]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[39]  Wh Sit,et al.  Cancer Genomics & Proteomics , 2007 .

[40]  Acute leukemia. , 1966, California medicine.